180 related articles for article (PubMed ID: 8608647)
1. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).
Kadota J; Matsubara Y; Ishimatsu Y; Ashida M; Abe K; Shirai R; Iida K; Kawakami K; Taniguchi H; Fujii T; Kaseda M; Kawamoto S; Kohno S
Clin Exp Immunol; 1996 Mar; 103(3):461-6. PubMed ID: 8608647
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.
Sakito O; Kadota J; Kohno S; Abe K; Shirai R; Hara K
Respiration; 1996; 63(1):42-8. PubMed ID: 8833992
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1995 Jul; 108(1):116-22. PubMed ID: 7606944
[TBL] [Abstract][Full Text] [Related]
4. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.
Kadota J; Sakito O; Kohno S; Sawa H; Mukae H; Oda H; Kawakami K; Fukushima K; Hiratani K; Hara K
Am Rev Respir Dis; 1993 Jan; 147(1):153-9. PubMed ID: 8420410
[TBL] [Abstract][Full Text] [Related]
5. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.
Ashitani J; Mukae H; Nakazato M; Ihi T; Mashimoto H; Kadota J; Kohno S; Matsukura S
Eur Respir J; 1998 Jan; 11(1):104-11. PubMed ID: 9543278
[TBL] [Abstract][Full Text] [Related]
6. [Determination of the neutrophil chemotactic factor in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Oda H; Kadota J; Sakito O; Mukae H; Morikawa N; Shukuwa C; Senju R; Sawa H; Kusano S; Morikawa T
Kansenshogaku Zasshi; 1992 Apr; 66(4):441-7. PubMed ID: 1624836
[TBL] [Abstract][Full Text] [Related]
7. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil chemotactic activity in bronchoalveolar lavage fluid recovered from patients with diffuse panbronchiolitis.
Katsuki M
Kurume Med J; 1996; 43(4):279-87. PubMed ID: 9029897
[TBL] [Abstract][Full Text] [Related]
9. [A study of defensins in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Mukae H; Ashitani J; Nakazato M; Taniguchi H; Date Y; Ihi T; Shiomi K; Mashimoto H; Kadota J; Kohno S
Kansenshogaku Zasshi; 1995 Sep; 69(9):975-81. PubMed ID: 7594798
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of the inflammatory response to inhaled grain dust.
Becker S; Clapp WA; Quay J; Frees KL; Koren HS; Schwartz DA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1309-18. PubMed ID: 10508823
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1994 Oct; 106(4):1116-23. PubMed ID: 7924482
[TBL] [Abstract][Full Text] [Related]
12. [A study of bronchoalveolar lavage analysis in patients with diffuse panbronchiolitis--the results of low dose and long term erythromycin treatment].
Mukae H; Sakito O; Oda H; Senju R; Hiratani K; Kadota J; Fukushima K; Komori K; Kouno S; Hara K
Kansenshogaku Zasshi; 1991 Jun; 65(6):692-7. PubMed ID: 1919099
[TBL] [Abstract][Full Text] [Related]
13. [Elastase activity in bronchoalveolar lavage fluid from patients with diffuse panbronchiolitis].
Ninomiya H; Ichikawa Y; Koga H; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Jun; 65(6):672-80. PubMed ID: 1919096
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis.
Koga T
Kurume Med J; 1993; 40(3):139-46. PubMed ID: 8139213
[TBL] [Abstract][Full Text] [Related]
15. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
16. [A mechanism of usefulness of treatment with erythromycin for diffuse panbronchiolitis].
Ichikawa Y; Ninomiya H; Koga H; Tokunaga N; Tanaka Y; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Dec; 65(12):1501-7. PubMed ID: 1783799
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.
Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K
Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803
[TBL] [Abstract][Full Text] [Related]
18. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis.
Mukae H; Hirota M; Kohno S; Komori K; Fukushima K; Hiratani K; Kadota J; Hara K
Am Rev Respir Dis; 1993 Sep; 148(3):744-51. PubMed ID: 8103656
[TBL] [Abstract][Full Text] [Related]
19. Superoxide dismutase in alveolar macrophages from patients with diffuse panbronchiolitis.
Morikawa T; Kadota JI; Kohno S; Kondo T
Respiration; 2000; 67(5):546-51. PubMed ID: 11070461
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin.
Wei-xu H; Qin X; Zhu W; Yuan-yi C; Li-feng Z; Zhi-yong L; Dan H; Xiao-mu W; Guo-zhu H
Mol Immunol; 2014 Mar; 58(1):139-49. PubMed ID: 24355520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
